Cited by — TALAVE in Breast Cancer:
<i>BRCA1/2</i>
Mutation-Dependent Immune Remodeling after PARP Inhibition with Limited Checkpoint Engagement | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite TALAVE in Breast Cancer:
<i>BRCA1/2</i>
Mutation-Dependent Immune Remodeling after PARP Inhibition with Limited Checkpoint Engagement.
No admitted local citation edges point to this work yet.
